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We previously showed that the Bvg virulence control system regulates biofilm formation in Bordetella
bronchiseptica (Y. Irie, S. Mattoo, and M. H. Yuk, J. Bacteriol. 186:5692–5698, 2004). Analyses of the extra-
cellular components of B. bronchiseptica biofilm matrix revealed that the major sugar component in the matrix
was xylose, and linkage analysis indicated a majority of it to be in a 4-linked polymeric form. The production
of xylose was independent of Bvg regulation but instead was dependent on bacterial growth phase. In addition,
N-acetyl-glucosamine in the matrix was found to be important for the initial development of the biofilm. These
results suggest that B. bronchiseptica biofilm formation is growth phase dependent in addition to being
regulated by the Bvg virulence system.
A majority of bacterial species can grow in a multicellular
surface-associated community, widely referred to as a biofilm,
and these communities may be more representative of micro-
bial growths in their natural settings (11). Virtually all biofilms
studied have an extracellular matrix encasing the bacterial
cells, and the regulation of matrix formation appears to be
critical in the development of biofilms (3). Biofilm matrices
have been found to contain various organic materials, in-
cluding DNA (43), lipids (40), dead cells, and other debris
(42), but the key components are proteins and polysaccha-
rides (40). The importance of extracellular polysaccharides
and their components have been extensively analyzed in
several bacterial species.
Pseudomonas aeruginosa biofilm matrix has been extensively
characterized. Early studies showed that many P. aeruginosa
strains isolated from cystic fibrosis patients conferred a mu-
coidy phenotype on agar plates, and this was the result of the
overproduction of alginate (9). Alginate was hypothesized to
be a major component of P. aeruginosa biofilm matrix. How-
ever, biofilms of nonmucoid P. aeruginosa strains did not con-
tain alginate, and mutations in the genes required for alginate
biosynthesis had little or no effect on in vitro biofilm formation
(46). Instead, the pel and psl loci were recently characterized to
play major roles in the biosynthesis of extracellular polysac-
charides in the biofilms of this species (10, 17, 26). Poly-N-
acetyl-glucosamine polymers are found in biofilm matrices in a
large variety of bacterial species, including Staphylococcus spe-
cies and Escherichia coli (24, 25, 41), and their biosynthetic
pathways are highly conserved. Cellulose is also an important
component of E. coli and Salmonella enterica serovar Typhi-
murium biofilm matrix (48). These various studies also dem-
onstrate the complexity of the carbohydrate composition of the
various biofilm matrices, which almost always contain a num-
ber of different sugar residues. Different environmental condi-
tions for different species evidently affect biofilm formation,
and matrix contents are also likely to be equally dynamic. The
exact roles of polysaccharides in the development and function
of biofilm matrices are also speculative, although it is generally
thought that they can increase the adhesive properties of the
cells to aid in the surface-associated growth (3). Once biofilm
development has matured, the matrix may be important in
preserving the structural integrity. It has also been proposed
that the presence of the matrix may be important in achieving
pH homeostasis (40). The matrix may also provide a strong
barrier to such insults as antibiotics, resulting in a common
observation that bacterial biofilms are more resistant to most
antibiotics than planktonic cells (8).
Bordetella bronchiseptica is a gram-negative bacterial species
that chronically infects the respiratory tract of a wide range of
mammals. A majority of its virulence determinants are con-
trolled by a two-component signal transduction system, BvgAS
(for Bordetella virulence gene). In the virulent Bvg phase, the
response regulator BvgA becomes highly phosphorylated, and
the transcription of various Bvg-activated genes confers on the
bacterium its virulent phenotype. Virulence factors expressed
in the Bvg phase include adhesins such as filamentous hem-
agglutinin (FHA) and fimbriae as well as toxins/toxin delivery
systems such as adenylate cyclase/hemolysin (CyaA) and type
III secretion system. Unphosphorylated BvgA in the avirulent
Bvg phase is unable to transcriptionally activate such genes
(4). In between the transition of Bvg and Bvg phases there
appears to be at least one other distinct Bvg phase, called Bvg
intermediate (Bvgi) phase. There are specific genes that are
only expressed in the Bvgi phase (7), such as bipA (38). More-
over, adhesins such as FHA and fimbriae are also expressed in
the Bvgi phase in addition to the Bvg phase. However, toxins
such as CyaA are expressed in the Bvg phase but not the Bvgi
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phase. We previously showed that FHA is required for B.
bronchiseptica biofilm formation and proposed that the expres-
sion of CyaA suppresses biofilm via its association with FHA.
This results in the biofilm phenotype being predominantly ex-
pressed only when B. bronchiseptica is grown in the Bvgi phase
but not in the Bvg nor Bvg phase (15).
In this study, we examined the chemical composition of the
extracellular matrix of B. bronchiseptica biofilm, with particular
focus on the carbohydrate components. We found that xylose
is the major sugar residue in the matrix, a unique characteristic
compared to other known bacterial biofilm matrices. While the
protein factors that regulate biofilm formation in B. bronchi-
septica (FHA and CyaA) are Bvg regulated, the production
of the polysaccharides required for biofilm formation do not
appear to be under Bvg control. However, the expression of
xylose is primarily determined by the growth phase of the
bacteria. These observations suggest that multiple levels of
regulation are involved in biofilm formation in B. bronchi-
septica.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this
study are listed in Table 1. All Bordetella strains were grown on Bordet Gengou
agar (Becton Dickinson) supplemented with defibrinated sheep blood and Stainer-
Scholte (SS) liquid medium (37) at 37°C. E. coli strains were propagated in
Luria-Bertani medium unless otherwise specified. Caulobacter crescentus strains
were grown in peptone-yeast extract (PYE complex medium) at 30°C.
Construction of fluorescent B. bronchiseptica strains. Plasmids pCC2 and
pCC5 were constructed by replacing lacZYA in plasmid pCW09 (44) with the
genes (exclusive of their promoters) encoding yellow fluorescent protein (YFP)
and green fluorescent protein (GFP), respectively. In the resulting plasmids,
expressions of the YFP- and GFP-encoding genes are driven by a mutated bipA
promoter that is expressed at very high levels under both Bvgi- and Bvg-phase
conditions (P. A. Cotter, unpublished data). These plasmids were introduced
into RB53i by conjugation where they integrated into a nonessential region of the
chromosome by homologous recombination. The genetic organization of the
resulting cointegrate strains was confirmed by PCR with primers CWBpGR and
CWSSHR3 (44).
Biofilm growth conditions. B. bronchiseptica biofilms were grown by three
different methods depending on the experiments. For matrix preparations, cul-
tures were grown in polystyrene tubes in a standard roller drum condition. For
quantitative crystal violet assays and enzyme-linked lectin-sorbent assays
(ELLA), biofilms were grown in a 96-well plate format as previously described
(15). For microscopic analyses, biofilms were formed in non-tissue-culture-
coated glass chamber slides (BD Falcon) as previously described (16).
Matrix preparations. The protocol for biofilm matrix preparation was modi-
fied from a previously described method (45). Virtually all cells of B. bronchi-
septica grown in conditions supporting biofilm formation in polystyrene tube
cultures are surface attached, leaving the liquid media completely clear (15).
Biofilms were scraped out of the tubes and resuspended in 16-fold (wt/vol) sterile
0.14 M NaCl and vortexed with glass beads. Supernatants were collected upon
centrifugation and filtration through sterile 0.22-m-pore cellulose acetate mem-
brane (Corning). Filtrates were dialyzed against deionized water and lyophilized
by freeze drying.
Analyses of matrix. Glycosyl composition analyses were performed as previ-
ously described (27, 47) by combined gas chromatography/mass spectrometry
(GC/MS) of the per-O-trimethylsilyl derivatives of the monosaccharide methyl
glycosides produced from the samples by acidic methanolysis. For glycosyl link-
age analyses, samples were permethylated, depolymerized, reduced, and acety-
lated, and the resultant partially methylated alditol acetates were analyzed by
GS/MS (47). Quantification of double-stranded DNA (dsDNA) and proteins in
the matrix were done with a PicoGreen dsDNA Quantitation kit (Molecular
Probes) and DC Protein Assay (Bio-Rad), respectively, according to the manu-
facturers’ protocols.
In situ lectin staining of biofilms. Mature B. bronchiseptica biofilms grown for
24 h in chamber slides were washed three times with phosphate-buffered saline
(PBS). Fluorescent dye-conjugated lectins (10 g/ml; Molecular Probes) in 300
l PBS were incubated with the samples for 30 min at room temperature. The
samples were subsequently washed three times with PBS, and the top chambers
were removed. Deconvolution micrographs of the stained biofilms were taken as
previously described (16).
Enzyme-linked lectin-sorbent assays (ELLA). ELLA procedures were carried
out as previously described (23), using Vaccu-Pette/96 (Scienceware) for the
wash steps. The experiments were done in sextuplicate, and the error bars
represent the standard deviations of the collected data.
Dispersin B digestion. B. bronchiseptica biofilms were treated with poly-N-
acetyl-glucosaminidase from Actinobacillus actinomycetemcomitans (dispersin B,
1,000 U/mg) (18, 19) by two methods, with nearly identical results. Wells of
microtiter plates were pretreated with 50 g/ml dispersin B in 150 l SS medium
at room temperature for 1 h, and the solution was removed by inverting the plate
before B. bronchiseptica inoculation. Alternatively, 50 g/ml dispersin B was
added simultaneously upon bacterial inoculation. Biofilms were allowed to form
for only 6 h before crystal violet quantitation. Dispersin B was inactivated by heat
killing at 95°C for 40 min.
Xylose bioassay. A C. crescentus xylose bioassay strain was grown in PYE plus
5 g/ml kanamycin at 30°C with aeration overnight prior to the assay. Sugar
solutions were filtered through sterile 0.22-m-pore polyvinylidene difluoride
(PVDF) membranes (Millipore) and serially diluted. Likewise, B. bronchiseptica
cultures were centrifuged, and the supernatants were filtered through the PVDF
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Description Source or reference
B. bronchiseptica
RB50 Wild-type sequence strain 5
RB53 bvgS-C3, Bvg phase-locked derivative of RB50 5
RB53i bvgS-C3, bvgS-I1 Bvgi phase-locked derivative of RB50 6
RB54 bvgS, Bvg phase-locked derivative of RB50 5
RB58 cyaA derivative of RB50 13
RB53i GFP RB53i carrying pCC5 This study
RB53i YFP RB53i carrying pCC2 This study
E. coli
DH5 Cloning strain BRL, Gaithersburg, MD
SM10pir Conjugation donor strain 28
C. crescentus CB15N xylX::Pxyl-gfp CB15N chromosomal xylX::gfp fusion This study
Plasmids
pCW09 44
pCC2 This study
pCC5 This study
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membranes. Log-phase growth was monitored by measuring and graphing the
optical density at 600 nm read-out of the cultures as well as plating the bacteria
to verify the measurements. Mid- and late stationary phases were determined at
24 and 48 h after inoculation, respectively. Samples were distributed in at
least triplicates of 100-l aliquots per well in a clear non-tissue-culture-coated
polystyrene 96-well microtiter plate. Overnight C. crescentus bioassay strain cul-
ture was added at 1:20 and incubated at 30°C for 2 to 24 h. GFP expression was
read by a plate reader through excitation 360 nm and emission 460 nm filters at
an excitation wavelength of 485 nm and an emission wavelength of 528 nm.
Standard deviations are represented by the error bars in the corresponding
figures.
RESULTS
Analyses of the extracellular matrix of Bordetella bronchisep-
tica biofilm reveal that xylose is the primary carbohydrate
component. In situ detection of biofilm matrix using specific
lectin binding assays has been previously performed on P.
aeruginosa grown on filter membranes to determine the pres-
ence of carbohydrates in these structures (39). We have pre-
viously shown that B. bronchiseptica cells can form distinct
microcolony-like structures on glass surfaces that are typical of
biofilms (15, 16). In this study, we used various fluorescently
labeled lectins to examine the presence of carbohydrates
within the B. bronchiseptica biofilm and also to determine the
localization of the carbohydrates in relation to the bacterial
cells in the biofilm structure. As shown in Fig. 1, wheat germ
agglutinin (WGA) bound to the extracellular substances pri-
marily in the interior of the biofilm microcolonies formed by
recombinant B. bronchiseptica expressing YFP. In addition, we
did not observe WGA binding to the bacterial cells, supporting
the idea that the lectin is bound to a secreted matrix that is not
part of the cellular structure. In situ stainings were also done
with other lectins, including Griffonia simplicifolia isolectin IB4
(Fig. S1 in the supplemental material). Similar staining pat-
terns were observed where IB4 specifically bound only to the
extracellular matrix, essentially confirming the presence of the
extracellular component of the biofilm that contains complex
carbohydrates.
We also used enzyme-linked lectin-sorbent assay (ELLA)
for the semiquantitative measurement of extracellular polysac-
charide in the B. bronchiseptica biofilm. ELLA is similar in
principle to enzyme-linked immunosorbent assay, except that
labeled lectins instead of antibodies are used as probes (23).
ELLAs were directly done on biofilm formed within the 96-
well microtiter plate wells to measure the contents of the
matrix without disrupting the biofilm. Using WGA as a probe,
ELLA detected the extracellular carbohydrates in strains and
growth conditions that support biofilm formation (Fig. 2). B.
bronchiseptica biofilm forms biofilm in Bvgi phase. However, in
the absence of expression of the adenylate cyclase/hemolysin
gene (cyaA, which normally represses biofilm formation in the
Bvg phase), biofilm is formed in both the Bvg and Bvgi
phases (15). Figure 2 shows that the observed ELLA data are
consistent with the absence of biofilms in the wild-type bacte-
rium grown in the Bvg phase (RB50) and the Bvg phase-
locked strain (RB53), as no surface-bound carbohydrates were
detected in these samples. The Bvgi phase-locked strain
(RB53i) and cyaA mutant strains formed biofilms as expected
and correlated with the large amount of carbohydrates that was
detected by ELLA. It also appears that the expression of the
polysaccharides required for the formation of the biofilm ma-
trix was not limited to the Bvgi phase, even though biofilm
formation was normally maximal in this phase in the wild-type
FIG. 1. Deconvolution micrograph of Bordetella bronchiseptica bio-
film grown on a glass chamber slide stained with Alexa Fluor 350-
conjugated lectin wheat germ agglutinin (WGA). Recombinant B.
bronchiseptica expressing YFP is shown in yellow, and WGA is shown
in blue. The central picture shows a horizontal section while two
flanking pictures show vertical sections. The blue line and green line
indicate positions of the y-z section and x-z section, respectively. Red
lines indicate positions of the horizontal section.
FIG. 2. Quantitative analysis of Bordetella bronchiseptica biofilm
matrix with WGA ELLA. Bacteria were grown in 96-well plates for
24 h, and ELLA was performed as described in Materials and Meth-
ods. The Bvgi phase-locked strain (RB53i) and the cyaA mutant form
biofilms, while the wild-type bacteria grown in Bvg phase (RB50) and
Bvg phase-locked (RB53) strains do not (15). The strong binding of
WGA to the wells containing the biofilm-forming strains indicates the
presence of surface-associated N-acetyl-glucosamine residues within
the biofilm matrix. The absence of WGA binding to the samples
containing RB50 and RB53 indicates the absence of matrix material.
OD405, optical density at 405 nm.
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bacteria, since polysaccharides could be readily detected in the
Bvg phase in the cyaA mutant.
To further characterize the contents of the biofilm matrix,
glycosyl composition and glycosyl linkage analyses were done
on purified matrix samples; the results are shown in Table 2
and Table 3, respectively. Interestingly, xylose was found to be
the major component of the biofilm matrix. Linkage analysis
indicated that the majority of the xylose polymers were in a
4-linked form, different from a widely characterized plant xy-
lose polymer, xylan. There is also evidence of some branching
occurring with the xylose residues. Consistent with the WGA
(specific for N-acetyl-glucosamine) binding data, N-acetyl-glu-
cosamine was also found in the matrix. However, IB4 has
binding specificity to N-acetyl-galactosamine end groups and
terminal -galactosyl residues (32), but neither residue was
detected in significant quantities in our analyses. This suggests
that the IB4 lectin used in in situ staining may have nonspecific
recognition of other sugars in the matrix.
In addition to polysaccharides, some lipids were also de-
tected from the matrix samples by gas chromatography. Fatty
acids with chain lengths of 12:0, 14:0, 16:1, 16:0, and 18:0 were
the major lipid components from the purified matrix samples
(data not shown). Proteins and dsDNA were quantitated
from the matrix, measuring at approximately 10 mol% of
protein and approximately 0.01 mol% of dsDNA per sam-
ple. Since we cannot exclude the presence of normal cellular
components in the biofilm matrix samples, there is likely to
be present some lipopolysaccharides (LPS) from the outer
membrane. However, the major sugar residue detected is
not derived from LPS, as xylose is not a component of LPS
from Bordetella species (36).
An important observation is that the glycosyl composition
(Table 2), glycosyl linkage (Table 3), and the lipid composition
(data not shown) were not found to be significantly different
between samples from biofilms formed in the Bvgi phase
(made by the RB53i phase-locked strain) and that from the
Bvg phase (made by a cyaA mutant). This is consistent with
the aforementioned idea that while overall biofilm formation is
regulated by BvgAS systems via differential expression of FHA
and CyaA in the Bvg and Bvgi phases (15), the matrix con-
tents and their expression do not appear to be significantly
different in the Bvg and Bvgi phases.
N-acetyl-glucosamine may be critical for the early biofilm
development stage. Poly-N-acetyl-glucosamine has been impli-
cated to play a major role in biofilm development for various
bacterial species (24, 25, 41). In Actinobacillus actinomycetem-
comitans, poly-N-acetyl-glucosamine is found in the biofilm
matrix but may be degraded by the enzyme dispersin B for
cellular detachment and dispersal to occur (19). In order to
investigate whether the N-acetyl-glucosamine found in the B.
bronchiseptica matrix is important for biofilm formation, bio-
films preformed in vitro on polystyrene surfaces were treated
with dispersin B and quantitated by crystal violet. Mature bio-
films (grown for 24 h) treated with dispersin B did not show
any decrease in the amount of attachment to the plastic sur-
face, even at concentrations that were effective for disruption
of other bacterial biofilms (data not shown). However, if we
pretreated the polystyrene surfaces with dispersin B before
inoculation of bacterial cells, biofilm formation was signifi-
cantly inhibited (Fig. 3). Dispersin B that was heat inactivated
did not inhibit biofilm formation. Dispersin B did not inhibit
planktonic growth of B. bronchiseptica (data not shown). This
observation suggests that during the initial phases of biofilm
formation, the formation of N-acetyl-glucosamine polymers in
the matrix is critical to further development of the biofilm
structure to its mature form. The ineffectiveness of dispersin B
on mature biofilms might indicate that once the mature biofilm
structure is formed, its integrity no longer depends on N-
acetyl-glucosamine linkages or that these are no longer acces-
sible to the enzyme in the mature biofilm structure. The latter
FIG. 3. Crystal violet quantitative assay of 6-h biofilm grown in
96-well plates precoated with dispersin B (DspB). Wells were pre-
coated with 50 g/ml of DspB and then inoculated with Bvgi phase-
locked B. bronchiseptica for growth for 6 h. Biofilm formation was
significantly lower in the presence of DspB than the controls with-
out the enzyme and heat-inactivated DspB. OD595, optical density
at 595 nm.
TABLE 2. Carbohydrate contents of B. bronchiseptica biofilm
in Bvg phase and Bvgi phase
Biofilm matrix Glycosyl residue Mol%
RB53i (Bvgi) Xylose 69.7
Mannose 1.9
Glucose 12.9
Heptose 1.5
N-Acetyl-glucosamine 14.0
cyaA (Bvg) Xylose 82.1
Mannose 1.7
Glucose 8.9
Heptose 0
N-Acetyl-glucosamine 7.3
TABLE 3. Linkage analyses of biofilm matrix from Bvg phase
and Bvgi phase
Biofilm matrix Glycosyl residue Mol%
RB53i (Bvgi) 4-Linked xylofuranosyl 73.3
4-Linked glucopyranosyl 8.5
2,4-Linked xylofuranosyl 1.4
Terminal glucopyranosyl 10.1
Terminal xylofuranosyl 6.8
cyaA (Bvg) 4-Linked xylofuranosyl 75.3
4-Linked glucopyranosyl 4.5
2,4-Linked xylofuranosyl 1.8
Terminal glucopyranosyl 10.1
Terminal xylofuranosyl 6.8
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may be more likely, as mature biofilms treated with dispersin B
demonstrated similar binding to WGA (specific for N-acetyl-
glucosamine) compared to untreated biofilms (data not
shown).
Xylose is produced primarily in the stationary growth
phase, but production is not regulated by Bvg. Although the
involvement of N-acetyl-glucosamine may be important in
building a biofilm, xylose is the major component of the B.
bronchiseptica matrix, and understanding its roles will be crit-
ical for studying the development of B. bronchiseptica biofilm.
There is no described or published lectin that has a binding
specificity to xylose. A convenient method for detecting xylose
was required, and we developed a quantitative xylose detection
bioassay. A Caulobacter crescentus strain was constructed con-
taining a xylose-inducible promoter controlling the expression
of a gfp gene so that in the presence of xylose, GFP fluores-
cence could be quantitatively assessed. As shown in Fig. 4A,
strong GFP signals were detected from this strain in a xylose
concentration-dependent manner. Other sugars, such as glu-
cose and N-acetyl-glucosamine, do not induce GFP expres-
sion at any concentration. Besides xylose monomers, poly-
mers of xylose can also be detected by this Caulobacter
strain (data not shown), presumably after degradation to
monomers by enzymes from the bacteria. The C. crescentus
bioassay strain therefore allows for a reliable xylose-specific
detection method.
To determine if xylose production in B. bronchiseptica was
regulated by Bvg, mutant strains of the bacteria locked at
various specific Bvg phases were tested for xylose production
(Fig. 4B). The bacteria were grown overnight into stationary
phase, and all the supernatants of bacteria grown at any Bvg
phase were found to contain large amounts of xylose, indicat-
ing that xylose production was Bvg independent. However,
supernatants of bacteria taken at different stages of their
growth phases displayed an increase in xylose content, partic-
ularly in the stationary phase (Fig. 4C). Comparison of fluo-
rescence units normalized to CFU (Fig. 4C, bottom table)
indicates that xylose production increases significantly in the
stationary phase compared to the log phase, and the increase
of xylose content in the medium is not simply an accumulative
effect. Xylose expression also appeared to be Bvg independent,
since the xylose production profiles of B. bronchiseptica grown
in all phases were identical to each other.
DISCUSSION
We have previously shown that biofilm formation in Borde-
tella bronchiseptica is regulated by the Bvg virulence control
system and that the biofilm phenotype is maximal in the Bvgi
phase (15). This is in slight variance from another report (29),
but our results have been consistent and correlate well with the
observation that FHA (expressed in both Bvgi and Bvg
phases) is required for biofilm formation, while CyaA (ex-
pressed only in the Bvg phase) represses this phenotype.
The presence of extracellular polysaccharides is one of the
hallmarks of all described microbial biofilms (3). In this
study, we characterized the biofilm matrix of B. bronchisep-
tica and found that it primarily consists of polysaccharides,
although lipids, DNA, and proteins are also present. Inter-
estingly, the major composition of the polysaccharides was
4-linked xylose polymers.
Eukaryotes have previously been characterized to synthesize
xylose by a conserved metabolic mechanism from yeast, plants,
and mammals. Synthesis routes involve two-step enzymatic
activities of UDP-glucose dehydrogenase, which converts
UDP-glucose to UDP-glucuronic acid, and UDP-glucuronate
decarboxylase, which converts UDP-glucuronic acid to UDP-
xylose (2, 12, 31). BLAST searches of the Bordetella genome
revealed no obvious homologues of either of the enzymes,
suggesting prokaryotes may utilize a different metabolic path-
way or functional analogues with few sequence similarities.
Although small quantities of xylose have been detected in
specific growth conditions of some bacteria (46), literature
searches did not reveal any reports that prokaryotes can syn-
thesize xylose de novo. Bordetella species are grown in Stainer-
Scholte (SS) medium, which does not include any carbohy-
drates (37), since they cannot utilize sugars as a carbon source.
The classical glycolytic pathway is nonfunctional in Bordetella
species, as specific key enzymes in the glycolysis pathway are
absent in the Bordetella genome, although the gluconeogenesis
pathway appears to be intact (35). Casamino Acids and gluta-
mate are the primary carbon sources for Bordetella grown in SS
(37), and it is clear that the sugars found in the biofilm
matrix are synthesized de novo by B. bronchiseptica, possibly
via gluconeogenesis. The sugars synthesized and secreted by
this organism cannot be recycled back into the cell for an
energy source unless an alternative pathway, such as the
pentose phosphate pathway, is utilized. It implies that the
sugars we have detected in the biofilm matrix are most likely
to have been synthesized for the primary purpose of biofilm
matrix construction.
Although xylose appears to be the major component of the
matrix, N-acetyl-glucosamine may be important for the early
biofilm development. It is possible that the N-acetyl-glucos-
amine polymers serve as an additional “adhesive” to initiate
surface association, consistent with earlier suggestions of the
roles of extracellular polysaccharides in other biofilm systems
(3). Furthermore, xylose secretion appears to be more pro-
nounced in the stationary phase of growth, suggesting that the
matrix glycosyl composition may change throughout biofilm
development. Upon slowing of cellular replication during bio-
film formation, xylose polymers may populate the matrix to
reinforce the overall biofilm structure.
The thick polysaccharide matrix encapsulating the biofilms
has been suggested to have several roles. It may aid the bac-
teria to attach to surfaces during the early formation, eventu-
ally creating a structural foundation to preserve its architecture
(3). The matrix may function as a barrier to maintain a ho-
meostasis inside to create a more consistent microenvironment
(40) and also to prevent external chemicals and environmental
factors such as antibiotics from entering (8). It may also be
important for pathogenic bacteria in vivo to hide antigens on
bacterial surfaces normally recognized by the host immune
system by encapsulating the cells with polysaccharide polymers
that have lower immunogenicity. The role of biofilm formation
in promoting colonization and persistent chronic infections has
been documented in P. aeruginosa (21). We have also proposed
that B. bronchiseptica can form biofilms in the upper respira-
tory tract of infected hosts (15). Our more recent studies in-
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FIG. 4. Caulobacter crescentus xylose bioassay. (A) The Caulobacter xylose bioassay strain was added to serially diluted xylose, glucose, and N-acetyl-
glucosamine solution, and the GFP fluorescence read-outs were measured by a fluorescence microplate reader. Only xylose induced GFP expression in a
concentration-dependent manner. (B) Supernatants of overnight cultures of B. bronchiseptica strains RB50 (wild type), RB53 (Bvg phase locked), RB53i (Bvgi
phase locked), and RB54 (Bvg phase locked) were assayed. Xylose production appears to be Bvg independent, as all supernatant induced GFP expression of
the Caulobacter bioassay strain to similar levels. (C) Culture supernatants of RB50 (grown in Bvg phase) and RB53i (Bvgi phase locked) were collected at
different growth stages and assayed for xylose. The table at the bottom shows relative fluorescence units that have been normalized with B. bronchiseptica CFU
at the time of supernatant collection, and the reading from the late log phase was adjusted to 1 individually for Bvg readings and Bvgi readings. The relative
fluorescence unit/CFU values of early stationary phase, mid-stationary phase, and late stationary phase represent the fold increases of fluorescence units/B.
bronchiseptica CFU compared to the late log values. Most of the xylose was produced in the stationary phase.
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dicate that the epithelial surfaces of the nasal cavity serve as
the primary sites for biofilm formation in vivo (Y. Irie and
M. H. Yuk, unpublished data).
Developmental biology of biofilm formation has been most
well characterized in Pseudomonas species and Vibrio cholerae
(33). The initial attachment stage is often mediated by various
adhesins, such as the type IV pili in P. aeruginosa (34) and
mannose-sensitive hemagglutinin type IV pili in V. cholerae
(30). Stalk formation of P. aeruginosa microcolonies has been
suggested to be formed by cells downregulating pili, while the
mushroom caps have been formed by pili-motile cells climbing
the stalks (20). The detachment stage of biofilm has been
attributed to several factors and is not well understood. Poly-
saccharide lyases (1), cell death, and survival partially medi-
ated by phages within microcolonies (42), protease activity
(22), and quorum sensing affecting as yet unknown mecha-
nisms (3) may be involved in biofilm detachment. However, in
most studies of the biofilm development, the focus has mainly
been on protein factors affecting the cellular behaviors. There
are few reports on the differential expression of carbohydrates
in the biofilm matrix and how these processes may affect the
development of biofilm. This study presents evidence that B.
bronchiseptica produces xylose, the major component of this
bacterial matrix, primarily at the stationary phase of growth.
The dynamic expression patterns of carbohydrates in bacteria
have been investigated (14), but the integration of the knowl-
edge with biofilm formation has yet to be achieved.
We have shown that B. bronchiseptica biofilm forms primar-
ily in the Bvgi phase, with FHA being the primary factor that
is required for biofilm formation (15). However, it can also
form strong biofilms in the Bvg phase in the absence of CyaA
expression. Our present studies indicate that the carbohydrate
profile of the B. bronchiseptica biofilm matrix does not show
significant differences between Bvg and Bvgi phases. There-
fore, the primary driver of biofilm formation appears to be the
Bvg control system via its regulation of FHA and CyaA ex-
pression, but the expression of the carbohydrate components
of the biofilm matrix does not appear to be Bvg regulated.
Expression of specific sugars required for LPS synthesis have
been shown to be Bvg regulated (7), but the primary carbo-
hydrate components of the biofilm matrix do not constitute
any part of the known Bordetella LPS structure. A recent
microarray study of Bordetella species has produced a list of
Bvg-regulated genes (7), but an examination of these data
does not lead to any obvious candidate for gene products
that are involved in polysaccharide metabolism. One factor
that does affect the expression of the primary carbohydrate
component of the B. bronchiseptica biofilm matrix is the
growth phase of the organism, as xylose is maximally ex-
pressed in the stationary growth phase. Thus, a combination
of Bvg regulation and growth phases appears to be the
primary driver for formation of biofilm in B. bronchiseptica.
Bvg controls the expression of primary protein factor (FHA)
that is required for this phenotype, while the expression of
xylose, the primary carbohydrate component of the biofilm
matrix, is growth phase dependent. With the development of
the bioassay for detecting xylose, we have begun to perform
a genetic screen to identify specific genes that are involved
in its biosynthesis, and these studies should lead to a better
understanding of the mechanism and regulation of the for-
mation of the Bordetella biofilm matrix.
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